print
2/8/2010
Machupo Virus/Bolivian Hemorrhagic Fever (BHF)
James B. Peter, M.D., Ph.D.

Machupo virus, the cause of BHF was considered an example of the Pavlovskii rules of natural nidality1 until the host species, wild murid rodents (Calomys callosus), was shown to be monophyletic and of independent evolutionary history in northeastern Bolivia and not to occur throughout the species range.2 BHF is characterized by outbreaks with fatality rates ~15%,3 some evidence of intra-familial transmission4 and no evidence of asymptomatic disease. Rodent abatement is effective in controlling outbreaks.5 The last reports of BHF were in 1994.6

Culture, serology and PCR (cf. #7 for review) are available from the CDC whose assistance should be sought promptly and prior to any attempts to ship specimens. Recommendations are available about risk of transmission, isolation procedures, pre- and post-exposure prophylaxis and therapy.8 (cf. also #9). In patients suspected of having VHF, the differential diagnosis includes fulminant hepatitis, leptospirosis, malaria and meningococcal meningitis. Treatment of BHF with intravenous ribavirin is reported.10 South American hemorrhagic fevers were reviewed.11-13


See Also:
Viral Hemorrhagic Fevers

REFERENCES

  1. Pavlovskii EN. 1996 Natural nidality of transmissible diseases, with special reference to the landscape epidemiology of zooanthroponoses. University of Illinois Press, Urbana, p. 261.
  2. Salazar-Bravo J, Dragoo JW, Bowen MD, et al. Natural nidality in Bolivian hemorrhagic fever and the systematics of the reservoir species. Infect Genet Evol 2002;1:191-9.
  3. Mackenzie RB. Epidemiology of Machupo virus infection. I. Pattern of human infection, San Joaquin, Bolivia, 1962-1964. Am J Trop Med Hyg 1965;14:808-13.
  4. Kilgore PE, Peters CJ, Mills JN, et al. Prospects for the control of Bolivian hemorrhagic fever. Emerg Infect Dis 1995;1:97-100.
  5. Kuns ML. Epidemiology of Machupo virus infection. II. Ecological and control studies of hemorrhagic fever. Am J Trop Med Hyg 1965;14:813-6.
  6. No authors listed. Bolivian hemorrhagic fever--El Beni Department, Bolivia, 1994. MMWR Morb Mortal Wkly Rep 1994;43:943-6.
  7. Drosten C, Kūmmerer BM, Schmitz H, Gūnther S. Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res 2003;57:61-87.
  8. Centers for Disease and Control. Viral hemorrhagic fevers. www.bt.cdc.gov/agent/vhf/index.asp (Accessed Dec. 11, 2003).
  9. Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis 2001;32:446-56.
  10. Kilgore PE, Ksiazek TG, Rollin PE, Mills JN, et al. Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis 1997;24:718-22.
  11. Tesh RB. Viral hemorrhagic fevers of South America. Biomedica 2002;22:287-95.
  12. Charrel RN, de Lamballerie X. Arenaviruses other than Lassa virus. Antiviral Res 2003;57:89-100.
  13. Peters CJ. Human infection with arenaviruses in the Americas. Curr Top Microbiol Immunol 2002;262:65-74.